GPGiorgio Pellegrino

Giorgio Pellegrino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giorgio Pellegrino has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rate and Shape of Functional Decline in Amyotrophic Lateral Sclerosis Identify Clinically Distinct Amyotrophic Lateral Sclerosis Phenotypes

    by Andrea Calvo, Cristina Moglia, Antonio Canosa, Umberto Manera, Elisabetta Zucchi, Giulia Gianferrari, Ilaria Martinelli, Gabriele Mora, Sara Cabras, Francesca Palumbo, et al.

    Objective: The ALS Functional Rating Scale–Revised decline rate compresses trajectory shape into a single number, potentially missing distinct phenotypes. We tested whether shape identifies phenotypes that rate does not distinguish, and whether post‐hoc analysis recovers a hidden ultrarapid subgroup. Methods: From the Piemonte and Valle d'Aosta register (2000–2022), we applied 2 models to 1,686 amyotrophic lateral sclerosis patients: a Gaussian mixture model (GMM; rate axis) and a latent‐class mixed model (LCMM) with cubic splines (shape axis). Concordance, prognostic performance, calibration, and clinical utility were assessed at 24 months. External validation used the Emilia‐Romagna register. Results: The rate model identified 4 classes (GMM‐Slow 31%, GMM‐Inter‐slow 46%, GMM‐Inter‐fast 17%, GMM‐Catastrophic 6%; slopes −0.44 to −3.52 points/month); the shape model 4 (LCMM‐SlowLinear 46%, LCMM‐PlateauFall 23%, LCMM‐LateDecline 15%, LCMM‐RapidEarly 16%). Concordance was modest (kappa = 0.273). Adding shape to rate changed discrimination negligibly (C‐index 0.761 vs 0.755), but separated subgroups within rate classes (within GMM‐Catastrophic, 30.1 vs 12.0 months). LCMM‐LateDecline combined moderate early decline with reduced respiratory reserve (median forced vital capacity 83.5%) and 22.7‐month median survival. The combined model gave the greatest net benefit for the composite outcome. Of 945 patients excluded for sparse sampling, 367 were ultrarapid progressors with shorter survival than LCMM‐RapidEarly; findings replicated in the Emilia‐Romagna register. Interpretation: Rate and shape describe partially overlapping aspects of the disease. LCMM‐LateDecline, with moderate early decline yet occult respiratory compromise, is clinically challenging, and the 3‐visit criterion hides over half of ultrarapid patients. Rate predicts the overall burden of progression, whereas shape predicts the timing of deterioration. ANN NEUROL 2026

  • Open Access

    Factors associated with post-tracheostomy survival in Amyotrophic Lateral Sclerosis

    by Alessandra Maccabeo, Sara Cabras, Stefano Callegaro, Maria Ida Pateri, Francesca Pili, Antonio Canosa, Umberto Manera, Francesca Palumbo, Enrico Matteoni, Giorgio Pellegrino, et al.

    Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease characterized by upper and lower motor neuron degeneration. It leads to progressive muscle paralysis and ultimately results i...

  • Open Access

    Recalibration of the Frontal Behavioural Inventory Cut‐Off for Behavioural Screening in Amyotrophic Lateral Sclerosis

    by Barbara Iazzolino, Francesca Palumbo, Antonio Canosa, Stefano Callegaro, Vita Passidomo, Umberto Manera, Rosario Vasta, Enrico Matteoni, Sara Cabras, Giorgio Pellegrino, et al.

    Objective: The Frontal Behavioural Inventory (FBI) was validated in behavioural‐variant frontotemporal dementia (bvFTD) with a cut‐off of 25. We tested whether this threshold is appropriate in amyotrophic lateral sclerosis (ALS), where behavioural change is milder and partly confounded by motor pathology. Methods: We analysed 506 ALS patients with a valid FBI assessment. Behavioural impairment was defined using two complementary reference standards, to minimise dependence on any single behavioural instrument: a consensus rule (pathology on ≥ 2 of three independent instruments: Edinburgh Cognitive and Behavioural ALS Screen, Frontal Systems Behaviour Scale, Beaumont Behavioural Inventory) and Latent Class Analysis. ROC analysis identified the Youden‐optimal cut‐off; agreement was quantified by Cohen's κ ; internal validity was assessed by stratified 5‐fold cross‐validation. Total and subscale scores were analysed separately. Results: Among 345 complete‐case patients, 24.6% met criteria for behavioural impairment. The FBI total discriminated impairment well (AUC 0.855, 95% CI 0.806–0.898). The Youden‐optimal cut‐off was FBI ≥ 9 (sensitivity 0.87, specificity 0.74), whereas the legacy cut‐off of 25 showed sensitivity 0.22. Subscale recalibration yielded cut‐offs of FBI‐Apathy ≥ 7 (AUC 0.808) and FBI‐Disinhibition ≥ 4 (AUC 0.851). Conclusions: In ALS, the bvFTD‐derived threshold of 25 misses most patients with behavioural involvement. FBI ≥ 9 is a promising candidate ALS‐specific screening threshold, with scores ≥ 15 indicating a higher probability of behavioural involvement; exploratory subscale thresholds of ≥ 7 for Apathy and ≥ 4 for Disinhibition are also proposed. These cut‐offs substantially improve sensitivity while maintaining acceptable specificity, but require prospective external validation before replacing current practice.

  • Open Access

    What do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions

    by Andrea Calvo, Cristina Moglia, Stefano Callegaro, Antonio Canosa, Umberto Manera, Gabriele Mora, Sara Cabras, Francesca Palumbo, Enrico Matteoni, Alessandra Maccabeo, et al.

    Background: The ALS-OPM 3.3 classification stratifies incident ALS through three axes: onset region (O), propagation time (P) and motor-neuron pattern (M). We assessed whether OPM 3.3 improves prognostic discrimination over established classifications and characterised how it decomposes their prognostic signal in a population-based cohort. Methods: In the prospective Piedmont and Aosta Valley ALS Register (2000–2022), patients were classified on the three axes; M was operationalised as M_3class (M0 balanced, M1d UMN-predominant, M2d LMN-predominant), with the PLS-spectrum M1p analysed separately. Outcome was survival (death or tracheostomy) from onset. Multivariable Cox models (O, P1(n), M_3class, age, sex) underwent bootstrap optimism-correction and fivefold cross-validation, and were compared against alternative taxonomies and clinical staging systems. Results: Amongst 2,738 non-PLS patients (2,561 events, 93.5%), median survival differed across M classes (M0 27.0, M2d 36.0, M1d 41.9 months). OPM 3.3 outperformed the bulbar/spinal dichotomy but matched the classical phenotype (optimism-corrected C-index 0.703, 95% CI 0.685–0.719 vs 0.701). In the arm-proximal cell (95.7% M2d), the O2p protective effect vanished after M adjustment (HR 0.99, 95% CI 0.79–1.24), whilst M2d retained HR 0.83 (95% CI 0.72–0.95), showing prognosis reflects motor-neuron pattern, not anatomy. Adding King’s, Milano-Torino (MiToS), or Fine’til 9 (FT9) clinical staging further improved discrimination. Conclusions: OPM 3.3 did not improve discrimination over established phenotypes but decomposed their prognostic signal into independently interpretable dimensions. Favourable prognosis of arm-proximal/flail-arm onset reflects the underlying LMN-predominant phenotype, not onset site. The motor-neuron axis is robust to the treatment of the propagation axis and independent of clinical staging.

  • Open Access

    Early Cognitive and Behavioral Changes in Primary Lateral Sclerosis: A Population‐Based Study

    by Andrea Calvo, Cristina Moglia, Antonio Canosa, Umberto Manera, Rosario Vasta, Enrico Matteoni, Alessandra Maccabeo, Sara Cabras, Giorgio Pellegrino, Emilio Minerva, et al.

    Objective: Primary lateral sclerosis (PLS) is a rare upper motor neuron neurodegenerative disorder whose cognitive profile, particularly at early stages, remains incompletely defined. We aimed to characterize cognitive and behavioral features of PLS at diagnosis and compare them with predominant upper motor neuron amyotrophic lateral sclerosis (PUMN‐ALS) and healthy controls (HCs). Methods: Patients diagnosed with PLS between 2007 and 2021 were identified from the population‐based Piemonte and Valle d'Aosta ALS Register. Diagnoses were established according to consensus criteria, including early, probable, and definite PLS. All patients underwent comprehensive neuropsychological and behavioral assessment within 3 months of their first ALS center visit. Cognitive–behavioral status was classified using ALS–frontotemporal dementia (FTD) consensus criteria. Results: Thirty‐two PLS patients were included (mean disease duration, 25 months). Cognitive and/or behavioral impairment was identified in 29.3% of patients, most commonly affecting executive function, memory, and social cognition, including 21.1% early PLS. Compared with HCs, PLS patients showed poorer performance across several cognitive domains and higher anxiety and depression scores. Compared with matched PUMN‐ALS patients, PLS patients demonstrated slightly worse executive performance, while the overall frequency of cognitive–behavioral impairment was similar. Behavioral profiles differed qualitatively, with apathy more frequent in PUMN‐ALS. No PLS patient met criteria for frontotemporal dementia. Interpretation: Cognitive and behavioral impairments are already detectable at the time of diagnosis in a substantial proportion of patients with PLS, including early PLS, supporting the view of PLS as a multidimensional neurodegenerative disorder with early extramotor involvement.